You can buy or sell HBIO and other stocks, options, ETFs, and crypto commission-free!
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. Read More It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
52 Week High
52 Week Low
Yahoo FinanceMar 19
Edited Transcript of HBIO earnings conference call or presentation 28-Feb-19 9:30pm GMT
Q4 2018 Harvard Bioscience Inc Earnings Call HOLLISTON Mar 19, 2019 (Thomson StreetEvents) -- Edited Transcript of Harvard Bioscience Inc earnings conference call or presentation Thursday, February 28, 2019 at 9:30:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * Corey Manchester Harvard Biosci...
Stock Price, News, & Analysis for Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers physiology, cell, and molecular instruments, such as traditional syringe pump and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, and Hugo Sa...
Simply Wall StMar 8
If You Had Bought Harvard Bioscience (NASDAQ:HBIO) Stock Three Years Ago, You Could Pocket A 34% Gain Today
Buying a low-cost index fund will get you the average market return. But across the board there are plenty of stocks that underperform the market. For example, the Harvard Bioscience, Inc. (NASDAQ:HBIO) share price return of 34% over three years lags the market return in the same period. Unfortunately, the share price has fallen 16% over twelve months. See our latest analysis for Harvard Bioscience Harvard Bioscience isn’t a profitable company, so it is unlikely we’ll see a strong correlation between its ...
Expected May 1, After Hours